Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Titel:
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Auteur:
Fehrenbacher, Louis Spira, Alexander Ballinger, Marcus Kowanetz, Marcin Vansteenkiste, Johan Mazieres, Julien Park, Keunchil Smith, David Artal-Cortes, Angel Lewanski, Conrad Braiteh, Fadi Waterkamp, Daniel He, Pei Zou, Wei Chen, Daniel S Yi, Jing Sandler, Alan Rittmeyer, Achim